Jaffer A Ajani

Professor

  • 39868 Citations
  • 98 h-Index
1982 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Jaffer A Ajani is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles
Stomach Neoplasms Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Esophageal Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Stomach Medicine & Life Sciences
Survival Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Esophagogastric Junction Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1982 2019

A balancing act: dual immune-checkpoint inhibition for oesophagogastric cancer

Harada, K., Abdelhakeem, A. A. F. & Ajani, J. A., Jan 1 2019, In : Nature Reviews Clinical Oncology. 16, 1, p. 9-10 2 p.

Research output: Contribution to journalComment/debate

CD274 Antigen
Adenocarcinoma
Biomarkers
Morbidity
Mortality

A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer

Bang, Y. J., Kang, Y. K., Ng, M., Chung, H. C., Wainberg, Z. A., Gendreau, S., Chan, W. Y., Xu, N., Maslyar, D., Meng, R., Chau, I. & Ajani, J. A., Feb 1 2019, In : European Journal of Cancer. 108, p. 17-24 8 p.

Research output: Contribution to journalArticle

Esophagogastric Junction
Stomach
Disease-Free Survival
Placebos
Neoplasms

Biomarker analysis of the GATSBY study of trastuzumab emtansine versus a taxane in previously treated HER2-positive advanced gastric/gastroesophageal junction cancer

Shah, M. A., Kang, Y. K., Thuss-Patience, P. C., Ohtsu, A., Ajani, J. A., Van Cutsem, E., Hoersch, S., Harle-Yge, M. L. & de Haas, S. L., Jul 12 2019, In : Gastric Cancer. 22, 4, p. 803-816 14 p.

Research output: Contribution to journalArticle

Esophagogastric Junction
Stomach
Biomarkers
Survival
Neoplasms

Can PD-L1 expression evaluated by biopsy sample accurately reflect its expression in the whole tumour in gastric cancer?

Yamashita, K., Iwatsuki, M., Harada, K., Koga, Y., Kiyozumi, Y., Eto, K., Hiyoshi, Y., Ishimoto, T., Iwagami, S., Baba, Y., Miyamoto, Y., Yoshida, N., Komohara, Y., Ajani, J. A. & Baba, H., Jul 30 2019, In : British journal of cancer. 121, 3, p. 278-280 3 p.

Research output: Contribution to journalArticle

Stomach Neoplasms
Ligands
Biopsy
Neoplasms
Cell Death
Stomach Neoplasms
Survival
Therapeutics
Stomach
Adenocarcinoma